Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 21, 2003. The report details specific corporate actions regarding director share interests, employee trust transactions, and a share re-purchase program authorized by shareholders at the Annual General Meeting on May 20, 2002.
Key Financial Metrics
The filing does not provide consolidated financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on equity transactions and share price data related to specific events.
- Share Re-purchase Price: 1159.1233p per ordinary share.
- Director Share Purchase Price: $37.210 per American Depository Share (ADS).
- Trust Share Sale Price: £11.885 per ordinary share.
Material Changes and Transactions
The filing reports the following material equity movements:
- Share Re-purchase: On March 20, 2003, the company purchased 862,000 ordinary shares for cancellation.
- Director Interest (Dr. L. Shapiro): 399 ADS were purchased on March 19, 2003, under the Scientific Advisory Board Share Allocation Plan.
- Employee Trust Transactions: The GSK Trust sold 4,674 ordinary shares and transferred 6,986 ordinary shares on behalf of participants in the Glaxo Wellcome 1999 Long Term Incentive Plan.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a procedural report of share ownership changes and re-purchase activities.
Investor Verification Checklist
- Verify the total number of shares remaining in the treasury following the cancellation of 862,000 shares.
- Confirm the impact of the share re-purchase on the company's total share count and earnings per share.
- Review the full terms of the GlaxoSmithKline Scientific Advisory Board Share Allocation Plan and the Glaxo Wellcome 1999 Long Term Incentive Plan.
- Check subsequent filings for the aggregate volume of shares re-purchased under the authority granted on May 20, 2002.